Jianfa Pharmaceutical (301584.SZ) is expected to increase its net profit attributable to the parent company in the first half of the year by 140 million to 160 million yuan, a year-on-year growth of 2.16% to 16.76%.

Zh tng cijng APP xn, jinf zh xn (301584.SZ) fb gnggo, gngs yj 2026 nin shngbn nin gush y shngsh gngs gdng de jnglr wi 14 y yun zh 16 y yun, tngb zngzhng 2.16% zh 16.76%. Intelligent Financial APP News, Jianfa Zhixin (301584.SZ) announced that the company expects the net profit attributable to shareholders of the listed company in the first half of 2026 to be between 1.4 billion yuan and 1.6 billion yuan, an increase of 2.16% to 16.76% year-on-year.